TARO PHARMACEUTICAL INDUSTRIES LTD — Revenue by Fiscal Year
14 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/ba293da6-aea0-43cb-b466-939b9b94ce7f/serie/revenue
| Fiscal year | Revenue | Period | Evidence |
|---|---|---|---|
| FY 2022 | $573.0M | 2022-04-01 – 2023-03-31 | evidence 0000950170-23-030778 |
| FY 2021 | $561.3M | 2021-04-01 – 2022-03-31 | evidence 0000950170-22-012998 |
| FY 2020 | $549.0M | 2020-04-01 – 2021-03-31 | evidence 0001564590-21-033341 |
| FY 2019 | $644.8M | 2019-04-01 – 2020-03-31 | evidence 0001564590-20-029846 |
| FY 2018 | $669.9M | 2018-04-01 – 2019-03-31 | evidence 0001564590-19-022978 |
| FY 2017 | $661.9M | 2017-04-01 – 2018-03-31 | evidence 0001564590-19-022978 |
| FY 2016 | $879.4M | 2016-04-01 – 2017-03-31 | evidence 0001564590-19-022978 |
| FY 2015 | $950.8M | 2015-04-01 – 2016-03-31 | evidence 0001564590-16-020459 |
| FY 2014 | $862.9M | 2014-04-01 – 2015-03-31 | evidence 0001193125-15-241661 |
| FY 2013 | $759.3M | 2013-04-01 – 2014-03-31 | evidence 0001193125-14-259627 |
| FY 2012 | $671.0M | 2012-04-01 – 2013-03-31 | evidence 0001193125-13-279895 |
| FY 2011 | $505.7M | 2011-01-01 – 2011-12-31 | evidence 0001193125-12-150475 |
| FY 2010 | $392.5M | 2010-01-01 – 2010-12-31 | evidence 0001193125-12-150475 |
| FY 2009 | $355.9M | 2009-01-01 – 2009-12-31 | evidence 0001193125-12-150475 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
TARO PHARMACEUTICAL INDUSTRIES LTD — all facts · Net Income · Operating Income